The survival rate for stage IA triple-positive breast cancer is over 90%.
Triple-positive breast cancer is also known as immunohistochemistry test result, which indicates that the results of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 are positive, and the tumor volume of early breast cancer is less than 3 cm, and there is no lymph node, distal organ metastasis, etc., so it can be removed through surgery to achieve a cure, with a cure rate of more than 90%.
Stage IA of triple-positive breast cancer is still based on radical surgical resection, and after surgery, radiotherapy and chemotherapy can be carried out according to the results of pathological tissue examination, so as to reduce the chances of recurrence and metastasis in the later stage.
Only part of triple-positive breast cancer stage ⅠA has recurrence to make the condition worse and jeopardize the individual’s life because of inadequate postoperative care or incomplete surgical resection.
It is recommended to consult the doctor in time and carry out standardized treatment under the doctor’s guidance to prolong the survival period and improve the prognosis of stage IA triple-positive breast cancer.